Sayed Qayem Hussain was relaxing on his office desk, just after attending an office party hosted in his

farewell at his Manhattan Office of Johnson & Johnsons. His parent company has acquired Advanced Chemical Industries Limited (ACI) of Bangladesh, and has assigned Hussain to lead a prosperous company of a very promising industry of Bangladesh. Bangladesh being a third world country is relieved from Patent Right of the Pharmaceutical Industry, has a comparatively low labor cost and has Preferential Export Right to many of the Developed Nation including the countries of European Union. Johnson & Johnsons acquired ACI to explore all the prospective horizon and establish its market dominance in Bangladesh as a follow-up of its rivals, such as Novartis, Roche, and other Pharma giants. Hussain joined Johnson & Johnsons in the year 1998 after his MBA with a Human Resource Management, and BBA in Finance major. He has been involved in the same job of leading the first stage at Venezuela when Johnson & Johnsons acquired a company there. Hussain pulled up all the files that was provided to him before his new assignment and began his investigation. Background ICI Plc of UK had a pharmaceutical business in Bangladesh. In 1992 the business was sold to management and the name of the company changed to Advance Chemical Industries Limited. ACI inherited the rich ICI culture of product quality, customer service and social responsibility and continuous to nurture. ACI is the first company in Bangladesh to obtain certification of ISO 9001 Quality Management System in 1995. ACI is also the first Company in Bangladesh to get certification of ISO 14001 Environmental Management System in 2000. ACI employees are proud of their work culture, business ethics and environmental consciousness. ACI values are embodied in its vision and mission statements. ACI quality and environmental concerns clearly state through declared policies. What was primarily a pharmaceutical business in 1992 with a turnover of tk.80 million with stagnant growth, the new management brought about fundamental changes in policies and has in year 2002 grown to over Tk. 2000 million in turnover through diversified business interest including personal care products, food products, animal health, agrochemicals and seeds in addition to gaining a strong position in pharmaceuticals. The earning per share is increasing from 2000 to 2002, which was 3.97 and 6.75 respectively. ACI represents principals like AstraZeneca, Eli Lilly, UCB, Searle and Fujisawa in pharmaceuticals business; Colgate-Palmolive, Heinz and Dabur in Consumer products

sector; Synzenta in Agrochemicals; Ranbaxy, Dabur, Wockhardt, Sanofi and Invesa in animal Health sector. It has five subsidiary companies and is one of the largest conglomerates in Bangladesh. The trading subsidiary of ACI represents in Bangladesh principals like ICI, ExxonMobile, Bayer, and Stahl. History of ACI Pharmaceutical Ltd Bangladesh is a country with plenty of people. Actually, these people are a bank of huge human resource. As the population grows the need for medications is increased. And as the most of the people of our country are below the poverty line, they always look for cast- effective and quality medications. To improve lives by providing cost-effective high quality pharmaceutical products ACI stated their operation with this mission. It holds the eight positions in the Bangladeshi Pharmaceutical market ACI Pharmaceutical Ltd. is one of the largest manufacturers of quality medicines in Bangladesh. In 1973, the UK based multinational pharmaceutical company, ICI plc, established a subsidiary in Dhaka, known as ICI Bangladesh Manufacturers Limited. In 1992 , ICI plc divested its share to local management , and the company was renamed Advanced Chemical Industries [ACI] Limited. ACI formulates and markets a comprehensive range of more than 125 products covering all major therapeutic areas, which come in tablet, capsule, powder, liquid, cream, ointment, gel and injection forms. ACI also imports products from world-class multinational companies like ASTRAZENECA, UK; ELILILLY, USA and UCB, BELGIUM and markets world-renowned brands like Diprivan, Fluothane, Nolvadex, Accolate, Meronem, Atarax, Humulin, Ceclor etc. in Bangladesh. ACI is actively engaged in introducing newer molecules and new drug delivery systems to meet the needs of the future. ACI introduced the concept of quality management systems by being the first company in Bangladesh to achieve ISO 9001 certification in 1995 and follows the policy of continuous improvement in all its operations. ACI maintains a congenial and supportive relationship with the healthcare community of Bangladesh, with the belief that business excellence can only be achieved through pursuit of quality by understanding, accepting, meeting and exceeding customer expectations.

The management of ACI, a competent team of professionals, thus operates with a progressive attitude to provide effective solutions to satisfy the customers needs, through its products and services of uncompromising quality. It is engaged in resource and development, manufacture and marketing of prescription and non-prescription pharmaceuticals. They realize that pharmaceuticals are directly to human lives and thus feel that it has an incalculable social liability of providing safe medicine. ACI pharmaceutical Ltd is perceives to be one of the finest business entities by the members with whom it interacts specially the physicians and other health care professionals. Most of the products that it actively markets enjoy leadership position demonstrating incomparable trust that it enjoys from the health care professionals. In 1992, this company entered in the international business arena with the export of basic materials to UK It had to face many hindrances in the beginning. Now they export their products in different countries. Presently they export in the 16 countries. Those are UK, USA, Germany, Holland, Italy, France, Hungary, Japan, China, Korea, Thailand, Malaysia, Indonesia, India, Pakistan, Singapore and Taiwan. They face the economic and social challenges in this century and they prepare themselves to step in to that. Whatever the challenges they face, their motto of providing both human and animal health care sector with the quality products will never be compromised. ACI pioneered in the launching of anti-migraine drug in Bangladesh. ACI motto is contributing in the both human and animal health sectors by providing important medications not available in our country. The company also diversified into new entities in the fine chemicals. They committed to achieve world class standards is not only limited to formulations but also to its fine chemical business. This policy ensures supply of cost effective quality materials to other local companies as well as for use in its own formulated products. After several years in this business, ACI realized the role of positive work ethic. As they are in such a business where ethic and moral values are very much needed. And regarding the pharmaceuticals business they are really following an ethic. Finally it is their strength to get customer satisfaction. Over the year of the company has acquires a high degree of the ability of transforming technological know ledge into commercially viable products through in house expertise and use of international consultant.

As they are new in the market and have good marketing channels and they are producing good quality medicines, so there is a scope for them to expand. They can increase the production capacity and try to make some new channels to cover more area and sell their product throughout Bangladesh. They can also increase their product line. If they introduce some new brands in the market then there is a chance to acquire good response from customers. Through its creation of subsidiaries and affiliation in overseas pharmaceutical markets, ACI has been actively working towards the internationalization process and building the brand image of the companys products worldwide. ACI has established an international marketing network, which has made it the largest exporter of pharmaceuticals from Bangladesh Mission ACI mission is to play a leading role in enhancing the quality of life and well being of the people of Bangladesh through responsible application of knowledge and skills. Vision To attain the vision ACI will devote its resources to provide products and services of high and consistent quality, which ensure value for money to its customers. Endeavor to attain a position of leadership in each category of its business To create an image for quality of its products and services, productivity of its operations and innovative abilities of its employees. To ensure superior return on investment through healthy and sustainable growth of the company. To contribute to the personal well being of their employees. To encourage and support qualitative improvement of the services of or distributors and suppliers. To participate in selected government / NGO projects and in community services for the attainment of social goals.

ACI business divisions ACI is concentrating in many businesses. The main business divisions are following below: Pharmaceuticals Health Care Consumer Brands Agribusinesses Trade Products Diagnostics and Medical Devices Name of the company Flyban Insecticides Ltd. ACI Trading Ltd. ACI Formulations Ltd. Mutual Trust Bank Ltd. Central Depository Bangladesh Ltd. Computer Technology Ltd. Apex Leather craft Ltd. Tetley ACI (BD) Ltd. Quality Policy ACIs mission is to achieve business excellence through quality by understanding, accepting, meeting and exceeding customer expectations. ACI follows international Standards of Quality Management System to ensure consistent quality of products and services to achieve customer satisfaction. ACI also meets all national regulatory requirements relating to its current businesses and ensure that current Good Manufacturing Practices (cGMP) as recommended by World Health Organization is followed for its pharmaceutical operations. Their primary mission is to contribute to better health and quality of life for people. The management of ACI commits itself to quality as the prime consideration in all its business decisions. All employees of ACI must follow documented procedures to ensure compliance with quality standards.

The pool of human resources of the company will be developed to their full potential and harnessed through regular training and their participation on seeking continuous improvement of work methods. Environmental Policy ACI Limited is committed to maintain the harmonious balance of our eco-system and therefore constantly seeks ways to manufacture and produce product in an eco-friendly manner so that the balance of nature remains undistributed and the environment remains sustainable. In pursuit of this goal, ACI will Comply fully with all local and national environmental regulations Conserve natural resources like water and energy for sustainable development, and adopt Ensure appropriate treatment of all effluents prior to discharge, to discharge, to prevent pollution or Ensure appropriate communication and cooperate with internal and external interested Create awareness on environmental issue among their employees and suppliers. Adopt modern waste management technology. Business Opportunities Drug & Drug Discovery Service: ACI Pharmas Drug & Drug Discovery Service offers contract services to: Pharmaceutical manufacturers, Biotech researchers, and Biopharmaceutical companies. They are open for business development collaboration, strategic alliances and joint venture. They offer quality services and support under one roof in the hands of highly qualified professionals. Their professionals are trained in some of the best laboratories in the world such as MIT, Cambridge, USA; UC Berkeley, USA; Max Plank Institute, Germany; and some of the best industrial organizations. Quality and Reliability is our hallmark of success. Customer satisfaction is their highest policy. All under an environment of high confidentiality. Helping to build a healthier society is their mission for the elevation of human suffering?

Business Development ACI Pharm's Business Development group works with the: Business Development Department of leading pharmaceuticals and biotechnology companies to acquire products for ACI Pharm's worldwide pharmaceutical business. Provides commercial input into the product development of leading pharmaceutical companies on global basis. To meet these objectives, ACI Pharm seeks to form alliances with biotechnology companies, small to medium sized pharmaceutical companies, academic institutions, and other organizations, which may have products and/or technologies, which fit into ACI Pharm's business objectives. Licensing candidates and manufacturers with vision to reach global customers are being sought in the areas of cardiovascular diseases, oncology, bone disorders, gastoentrology, immunology, infections, hematology, and cerebrovascular diseases. Corporate Information ACI Pharm is a highly regarded professional organization committed to quality health care. We aim to provide sound health and longer enjoyment of life for users of our products. ACI Pharm is a science based pharmaceutical company committed to meet the needs of its valued customers through: Research, Development, Supply, Distribution, and Marketing of the highest quality healthcare products. Since its inception, they have been striving to broaden our services and product ranges to meet market needs. ACI Pharm. Inc, is Canada based company-having offices in Canada, Europe, and Asia; They provide world-class knowledge and expertise to clients in their locality. Their mission guides them to be a leading research based "pharmaceutical provider of choice" for consumers worldwide.

As a team of Qualified Researchers, Production, Technical, Marketing, Management, and Sales force, they strive to accomplish the mission through their commitment to high values and ethics in healthcare. Consciousness on consumer-oriented strategies guided them to: Futuristic research, Commercialization of latest technologies, Superior customer service, Proficient distribution services, Long-term strategic alliances, and Advanced information technologies applications. Professionals at ACI Pharm have extensive and diverse pharmaceutical / healthcare industry experience and global business expertise. You will find us uniquely qualified to help you meet the challenges of guiding a product through its entire life cycle. Financial Performance Sales turnover increased by 25.4% and Gross Profit increased by 39.1%. Cost of Goods Sold was reduced to 69.3% from 72.3% of last year. These improvements are due to higher proportionate sales of pharmaceutical product than last year. Profit after tax increased by 19.04% to Tk. 109.18 million over the previous year. The Earning Per share (EPS) stood at 6075 this year against Tk. 5067 of last year. Six Years Comparative Statistics 1997-2002 Taka Particulars Authorised Capital Issued & Paid Capital Turnover (Net) Gross Margin Profit Before Tax Profit After Tax Current Assets 1998 500,000,00 0 161,700,00 0 963,316,61 4 315,950,87 0 68,173,879 1999 500,000,000 161,700,000 2000 500,000,000 161,700,000 2001 500,000,000 161,700,000 2002 500,000,000 161,700,000

1,199,463,56 1,410,616,96 1,637,408,23 2,052,913,53 6 5 1 6 360,015,967 402,365,474 453,333,979 630,665,988 74,758,879 94,929,607 64,129,607 694,845,668 136,715,428 91,715,428 816,320,886 163,602,582 109,180,668 1,062,983,16 9

52,673,879 58,258,879 535,009,47 687,478,392 2

Net Current Assets Shareowners Equity Dividend Current Ratio Quick Ratio Return on Equity Inventory Turnover Debtors Period W. C. Turnover F. A. Turnover Net Asset Per Share Market Price/ Share Earnings / Share Dividend / Share Dividend Ratio P E Ratio Div. Payout Ratio E Dividend Rate No. of Emps

296,407,29 2 499,230,44 4 40,425,000 2.16 0.89 10.55% 1.8 17 3.3 4.9 30.87 42.54 3.26 2.50 25% 13.05 77% 6% 1,047

273,778,940 508,573,073 48,510,000 1.49 0.51 11.46% 2.2 18 5.3 5.8 31.45 27.29 3.60 3.00 30% 7.58 83% 11% 1,161

236,216,896 516,107,680 56,595,000 1.52 0.49 12.43% 2.2 20 6 6.5 31.92 50.45 3.97 3.50 35% 12.71 88% 7% 1,157

206,400,779 547,185,608 60,637,500 1.34 0.57 16.76% 2.5 24 7.9 7.7 33.84 55.31 5.67 3.75 37.50% 9.75 66% 7% 1,284

192,222,033 590,383,526 60,637,500 1.22 0.54 18.49% 2.7 23 10.7 8.8 36.51 54.19 6.75 3.75 37.50% 8.03 56% 7% 1,662

Production Capacity Production capacity of the pharmaceutical unit 1 is 1,500,000-unit pack per 8hr/ month and current utilization is 136% and Production capacity of the pharmaceutical unit2 is 375,000 units per 8hr/month and current utilization is 82%. Production capacity of Animal Heath unit 4 is 175,00 unit 8hr/month and current utilization is 30%.

Medical information update

ACI will shortly introduce a flash mail service and its website updates for the members of medical profession with latest information for their professional practices. In Bangladesh, ACI introduced the concept of quality management by being the first company in Bangladesh to achieve ISO 9001 certification that reflects its commitment to quality in every aspect of business. ACI wishes to introduce a flash mail service that will update whenever latest information important for their professional practices becomes available.

The efficient management and expertise strengthen the industry being well equipped with modern machineries and equipments. The commercial production started in April 1992 with 8 (eight) antibiotic products. During end of 1996 the production range expanded up to 41 numbers. Recently ACI Pharmaceuticals Ltd achieved ISO 9001 for its Production, Distributions Marketing, Quality Control, and Sales. ACI covers the health care community of whole Bangladesh based in both urban and rural markets, through its 18 strategically located depots. Markets International market To fuel the continuous growth of ACI, the company has started exploring international markets. The quality of ACI products, strengthened by its ISO 9001 certification, has brought immediate success in Sri Lanka, Yemen and Myanmar. Product registration in Singapore has just been completed. Domestic market Being a developing country, the pharmaceuticals market and at the same time, the pharmaceuticals industry of Bangladesh is growing. In this growing market, ACI has been able maintain its growth above the market growth through its innovative marketing strategies as well as products and services of uncompromising quality. Scientific seminars ACI frequently arranges seminars and symposia covering a wide range of medical topics attended by members of health care community. The faculty of these programs usually consist of both reputed medical experts and experts from marketing team of ACI and its international principals. Continuing medical education of physicians and surgeons ACI regularly arranges CME programs of both physicians and surgeons all over the country. These programs cover medical problems frequently faced by the practitioners, update their knowledge, and make them aware of the new therapies and medical technologies. Responding to doctors queries It is the most regularly performed task of the marketing team of ACI. The company has developed a postage paid business reply care attached to every literature in which the doctors usually send their queries. ACI tried to provide a comprehensive answer to the

queries of the physicians covering all the details. The ACI is also planning to provide more specialized services to doctors of various disciplines. So doctors will prescribe more medicine of ACI. The medical department is also planning to publish helpful and practical handbooks or guidebooks of different disciplines. Medical illustration and audiovisual aids ACI is ready to assist in preparing presentation packages including computer slides, transparencies and printed text whenever medical experts wish to share their experiences and results of their research with the health care community. Reprint services ACI provides the doctors with reprints of selected publications on topics that can assist the doctors in their professional practices. Facilities The plant is well designed and well equipped with all latest facilities and state-of-the-art technologies. The responsibility team of plant workers, supervisors, officers and managers strictly follow cGMP recommended by WHO and In-process Quality control methodology for production and meets all national regulation requirements. All the departments of ACI Pharmaceuticals have well experienced professional parsons. The present sales are showing upward trend and it is expected that within next two years the sales will reach over 20 million Taka per month. This project is self financed and the factory has over 5 acres of land for further expansion and modernization. Thus the total endeavor is aimed at the welfare and good health of the people so as to present a healthy society. Company Profile Description of the Key Products of ACI Pharmaceuticals Ltd. Amoebicides Metronidazole 200 mg tablets Metronidazole 400 mg tablets Metronidazole 200 mg and Diloxanide Furoate 250 mg tablets Metronidazole 400 mg and Diloxanide Furoate 500 mg tablets Anthelmintics Mebendazole 100 mg tablets Mebendazole 200 mg tablets Mebendazole 100 mg Suspension

Antiallergic drugs Cetirizine Dihydrochloride 5 mg tablets Cetirizine Dihydrochloride 10 mg tablets Cyproheptadine Hydrochloride 2 mg tablets Cyproheptadine Hydrochloride 4 mg tablets Anticancer drugs Bicalutamide 50 mg tablets Etoposide 100 mg injection Flutamide 250 mg tablets Antidepressants and Anxiolytics Alprazolam 0.25 mg tablets Alprazolam 0.50 mg tablets Alprazolam 1 mg tablets Fluoxetine 10 mg tablets Fluoxetine 20 mg tablets Lorazepam 1 mg tablets Lorazepam 1 mg tablets Antibiotics and antibacterials Amoxycillin 250 mg Cloxacillin 250 mg capsules Amoxycillin 500 mg Cloxacillin 500 mg injection Amoxycillin 125 mg capsules/ syrup Amoxycillin 250 mg capsules Amoxycillin 500 mg capsules Azithromycin 250 mg tablets Cefadroxil 125 mg tablets Cefadroxil 250 mg tablets Cefadroxil 500 mg tablets Cefadroxil 125 mg suspension/drops Anti-Diabetic Ciprofloxacin 750 mg tablets Clarithromycin 250 mg tablets Gatifloxacin 200 mg tablets Gatifloxacin 400 mg tablets Lomefloxacin 400mg tablets Norfloxacin 200 mg tablets Analgesic & Anti-Inflammatory ACICOX 100mg Caps Antivirals Acyclovir capsules/cream Lamivudine 150 mg tablets Stavudine 15 mg capsules

Antihypertensives Amlodipine 2.5 mg tablets Amlodipine 5.0 mg tablets Atenolol 25 mg tablets Atenolol 50 mg tablets Carvedilol 3.125 mg tablets Carvedilol 6.25 mg tablets Carvedilol 12.5 mg tablets Carvedilol 25 mg tablets Diltiazem Hydrochloride 30 mg tablets Diltiazem Hydrochloride 60 mg tablets Doxazosin 2 mg tablets Doxazosin 4 mg tablets Enalapril Maleate 5 mg tablets Felodipine 2.5 mg tablets Felodipine 5 mg tablets Lisinopril 5 mg tablets Lisinopril 10 mg tablets Propranolol Hydrochloride 40 mg tablets Propranolol Hydrochloride 80 mg tablets Antidiabetics Gliclazide 40 mg tablets Gliclazide 80 mg tablets Metformin 250 mg tablets Metformin 500 mg tablets Metformin 850 mg tablets Rosiglitazone 2mg tablets Rosiglitazone 4mg tablets Rosiglitazone 8mg tablets Pioglitazone 15mg tablets Pioglitazone 30mg tablets Antifungals Clotrimazole 200 mg Fluconazole 200 mg capsules Miconazole Nitrate cream Antimalarials Mefloquine 250 mg tablets Mefloquine 500 mg tablets Antiulcerants Lansoprazole 15 mg capsules Lansoprazole 30 mg capsules Omeprazole 10 mg capsules Omeprazole 20 mg capsules Pantoprazole 40mg capsules Ranitidine 150mg tablets

Stavudine 20 mg capsules Zidovudine 300 mg tablets Anti- Cholesterol Guggulsterones 25 mg tablets Simvastatin 5 mg tablets Simvastatin 10 mg tablets Simvastatin 20 mg tablets Eye and Ear preparations Acyclovir BP 3% w/w ointment Ciprofloxacin 0.3% w/v drops/ ointments Neomycin 0.35% w/v drops/ ointments Norfloxacin 0.3% w/v drops/ ointments Ofloxacin 3.0 mg drops Pefloxacin 0.3% w/v drops Timolol 0.25% w/v drops

Anti-inflammatory Celecoxib 100mg capsules Celecoxib 200mg capsules Diclofenac Sodium 50 mg tablets Diclofenac 50mg tablets Paracetamol 500mg tablets Diclofenac Sodium 25mg/ml Injection Ibuprofen 200 mg tablets Ibuprofen 400 mg tablets Ibuprofen 600 mg capsules Ibuprofen 200 mg tablets Paracetamol 325 mg tablets Ibuprofen 400 mg tablets Paracetamol 325mg tablet Ketorolac Tromethamine 10mg tablets Meloxicam 7.5 mg tablets Meloxicam 15 mg tablets Nimesulide 100 mg tablets Nimesulide 50 mg dispensable tablets Nimesulide 10mg/ml suspension Nimesulide gel 1%w/w Piroxicam 10 mg capsules Piroxicam 20 mg capsules Rofecoxib 12.5mg tablets Rofecoxib 25mg suspension

Prescription Drugs Prescription drugs are drugs that are not locally available without a physician's prescription. Anti-convulsant Drugs Anti-Angina Drugs Anti-Fungal Drugs Anti-Itch Drugs Anti-Viral Drugs Anti-Diabetic Drugs Anti-Asthmatic Drugs Anti-Hypertensive Drugs Antibiotics Anti-Migraine Drugs Anti-Rheumatic Drugs Anti-Protozoal Drugs Tricyclic Anti-depressants Anti-Arrhythmic Drugs

Anti-nausea Drugs Anti- Parkinson Drugs Anti-Psychotic Drugs Muscle Relaxants Digitalis Drugs Anti-Gastroesophageal Reflux Drugs Anti-Retroviral Drugs Anti-Tuberculosis Drugs Anti-Ulcer Drugs Anti-Hemorrhoid Drugs Anti-Spasmodic Drugs Anti-malarial Drugs Non-steroidal Anti-inflammatory Drugs: Some can be bought over the counter; others are available only with a prescription from a physician or dentist. Immuno-Suppressant Drugs Anti-Insomnia Drugs Anti-helminthic Drugs Central Nervous System Stimulants Decongestants: Some decongestant products require a physician's prescription but there are also many non-prescription (over-the-counter) products. Anti-Coagulant Drugs Bone Disorder Drugs Infertility Drugs Topical Antibiotics: Some topical antibiotics are available with a prescription only. Diuretics Vasodilators: In the forms used for treating high blood pressure (tablets or injections), these drugs are available only with a physician's prescription. Blood-viscosity Reducing Drugs Beta Blockers Expectorants: Some products that contain are available only with a physician's prescription Anti-histamines: Some Anti-histamine products are available only with a physician's prescription. Penicillins Barbiturates Laxatives ACE inhibitors Anti-anxiety Drugs Urinary Anti-infectives MAO Inhibitors Opioid Analgesics Bronchodilators Ophthalmic Antibiotics

Smoking Cessation Drugs: Some products are available only with a prescription. Protease Inhibitor Anti-depressant Drugs Alpha1-adrenergic Blockers Tetracyclines

Products

ACI Pharm's Herbals and Nutraceuticals division is engaged in developing, producing and marketing herbal medicines, nutraceuticals and food supplements. They apply scientific knowledge of medicinal plants and herbs to meet the growing demand for natural health products. They use proprietary technologies to improve the efficacy of natural substances and conducts clinical studies that follow the rigorous guidelines of the pharmaceutical industry to provide empirical evidence of health benefits. The company employs experts in the fields of ethnobotany, nutrition, and various medical disciplines and works closely with major hospitals, patient groups and the food and health regulatory agencies. All products are manufactured in compliance with GMP standards of high quality control. Products are marketed around the world and include:

Promale DS Caplet Leverex Plus Capsule Brestplus Capsule Proslim Caplet Multivit Caplet

Femigorex Caplet Immuneplex Capsule Cardiopro Capsule Stresfree Capsule Glu Products

Polyflex DS Caplet Prosleep Capsule Asthacure Capsule Healthpro Caplet

ACI veterinary Science specializes in the development, manufacture, and marketing of original veterinary and nutritional products. The company has a broad range of nutritional, antibiotic, anthelmentics, blood protozoan disease, ruminotonic, flukicides, and Vitamin supplements to enhance animal health and productivity.

Products are marketed around the world and include: Antibiotics Flukicides Ruminotonic Anthelmentics Corticos Steroides Anti-Mycoplasmic Drugs Inflammary Infusion for Mastitis Drugs for Blood Protozoan Diseases Vitamins Supplements & Nutritional Products

Service Supply Management For Pharmaceutical customers: Supply management resource provides you the services of order management, supply management, and distribution support for pharmaceutical and medical-surgical supply needs. Supply Management offers advanced order management capabilities including full catalog searches, customer-specific pricing, product availability, and order status - all provided with up-to-the-minute, real-time accuracy. ACI Pharm is an important link between suppliers & buyers on global basis. Associate companies of ACI Pharm manufacture quality pharmaceutical products and are involved in Research and Development. They are a young, dynamic and growing company focused on supply chain management (distribution, supply, and marketing pharmaceutical products).

Pharmaceuticals Marketing & Management ACI Pharm. Inc, provides a full spectrum of market development, product development, sales force management, direct-to-consumer advertising, global product launches, and product life cycle management and targeted communications services in support of product launch. They provide technical expertise in regulatory affairs, industry training, sales and marketing training, international business development, registration, commercialization and management consulting. Their market chemicals, laboratory reagents, diagnostics, pharmaceuticals, nutraceuticals, herbaceuticals, and health food supplements. They also help companies and organizations to focus their efforts in order to capture niche markets. They maintain excellent partnerships with consumer product companies in understanding the regulatory hurdles and help us in market development. Their strategic alliances and in depth market knowledge enable us to deliver a full range of innovative product commercialization, marketing, and distribution offerings for many of the leading pharmaceutical manufacturers. With superb management skill, sound financial strength, and capability to maintain the strategic competitive advantage provide both the products and service of your choice. They offer customized solutions to each associate company and its products in different markets. Their people work closely with customers and professionals to understand consumer's changing and devise strategies to support their business objective. They commitment to meet the requirements of different types of pharmacies ushered their to develop various types of marketing tools. In pursuit of their vision for the future of healthcare, ACI Pharmaceutical offers a complete package in supply, distribution, and marketing. ACI Pharm's uniqueness is not only the breadth of service offerings, but also its ability to help us drive market share and capitalize on business opportunities when they arise, whether it's accelerating adoption during product launch or increasing market share from growth to maturity. Wherever your product is, and wherever you need to take it, you'll see the value of working with strategic thinkers who are committed to customized solutions- and a level of personal involvement that sets them apart.

Their day-to-day activities include: Preparation of regulatory affairs documentation. Registration of products with respective regulatory organization and ministry.

Trade mark and brand name registration with respective ministry. Market research and strategic marketing for associate companies. Product concept to product development and clinical trails. Obtain import licenses and temporary quotas for products. Preparation of culture and language based customized marketing communication materials, e.g. detail kits, promotional literature, advertising, seminars, etc.. Daily retail and wholesales customer visits by qualified professionals. Pharmaceuticals markets and products database management and supply. Systems analysis and development of user specific software for manufacturers, retailers, and hospitals.

The animal health division and the Present Problem The animal health division of ACI Pharmaceutical started its journey in the year 2000with the purpose to supply animal health care products to the market. And from the very beginning of their journey this division of ACI Pharmaceuticals was performing well to satisfy their in-house customers. They have started with a very small product line and within this short period of time they have increased the product line. At present they are having 50 different products including vitamin, Feed Premix and antibiotic. Although the animal health care division have some limitation but even though they have shown a good performance. And lastly it has been found that they have a huge demand in the local market. These demands compel them to supply product to the customers.

Unethical business policy of market ACI is a one of the best leading Pharmaceuticals Company in our country. ACI is also the first Company in Bangladesh to get certification of ISO 14001. ACI motto is to contribute in the both human and animal health sectors by providing important medications which are not available in our country. They face the economic and social challenges in our country. Whatever the challenges they face, their motto of providing both human and animal health care sector with the quality products will never be compromised. ACI employees are proud of their work culture, business ethics and environmental consciousness. After several years in this business, ACI realized the role of positive work ethic. As they are in such a business where ethic and moral values are very much needed. And regarding the pharmaceuticals business they are really following an ethic. But there are some unethical business policies in the medicine market that is very unexpected. In our country every year almost one new pharmaceutical company establish. For marketing their new products they follow the unethical business policy. Some of the small companies give bribe to some doctors to write down their medicines in the patients prescription. But it is very illegal according to our countrys law and also condemnable acts. In this way they want to expand their marketing. But it has a bad impact on medicine market. It will resist the improvement of quality of the medicines. And public health will be harmful. So, it should be strictly protected. Government should take the necessary step to stop these unethical businesses. By concerning of public it can resist. Under rate crisis In our country every year almost one new pharmaceutical company is being established. For marketing their new products they follow the unethical business policy. Some of the small companies give bribe to some doctors to write down their medicines in the patients prescription and some of the companies are trying to market there products under actual rates. They supply the medicines in the marketing below the average market rates. In this way they want dumping and influence into their products over other companies products. But it is very illegal according to our countrys law and also condemnable acts. In this way they want to expand their marketing. But it has a bad impact on medicine market.

In the case of promoting the product at present they do not have any promotional activity. They only have the brochure where they try to introduce their products. Besides the health care division does not have any separate marketing channel. The management of ACI Pharmaceuticals by the time has found a favorable notion from this animal health care Division. And for that reason they want to start a new journey. But they are having some problem regarding the market potential. So they need to justify the demand of the health care products. And for doing that they are facing some problems. Animal Health Care Products Vitade Oxin WS Sulfamix+K Enro 10 Tylos Vital C Polymix WP 10 for Layer Polymix WP 21 Polymix WP 22 Polymix Salinomicin-mix 12% Polymix Amprol-Mix 25% Polymix CLS 1500 WS Polymix SPS Super Polymix Flavomycin-Mix 10% Polymix Multivit Amino 26 Polymix SPT-5 Polymix Liquid Disinfectant Livasol WS Daxolite

Medicines - an important material for commercial poultry farm Unlike other countries, Bangladesh is also facing the problems of animal diseases. The diseases are affecting the Poultry Firms directly and indirectly. So, at any cost farmers are maintaining the firms out from diseases otherwise starting from epidemic to severe financial loss may incur. Usually Bacteria, Virus, Saprophytes, Fungus, Malnutrition, Chemical Reaction and some other unknown diseases are responsible for direct and indirect infections. Generally the Bangladeshi farmers do not know that much about the poultry diseases. Farmers think about the treatment after the diseases attack the poultry. Most of the cases small farmers do not show interest to take prevention about diseases in order to avoid the cost. Though some farmers has the vaccination, still they do not bother for the Chemical Reaction, malnutrition and other diseases and as a result they become the victim without being aware of it. Infections are always a big threat for Poultry health. Ranikhet, Gamboro, Faul Pox, Infectitous Broncataties, Coccideosis, Infectus Coraiga, Aflatoxicosis, Eggdrop syndrome etc are having a direct effect on poultry firms. If not controlled it can be turned into an epidemic. Also birds are affected with malnutrition for feeding of low quality foods. Medicines, Vaccines and Vitamins are very important among the other ingredients. Most of these ingredients are imported from Europe, America, Korea, Singapore, and India. There are some reputed companies who are importing and marketing these medicines, vaccines and vitamins. Now vaccines worth have 16-core and medicines worth of 60 core are available in Bangladesh but farmer are being deceived because of the supply of some low quality products from some companies. As small farmers are more dependent on dealers and agents, the possibility of being deceived is higher for them. The management of ACI Pharmaceuticals by the time has found a favorable notion from this animal health care Division. And for that reason they want to start a new journey. The animal health care division of ACI Pharmaceuticals thus has a good prospect in the present market. This is indeed a great opportunity of ACI to in crease their market. Some of them are doing unethical practice by supplying the medicines at a high rate, which is a huge waste of money. The farmers should be aware about them and they should collect the medicines from the reputed companies but recently farmers are becoming more aware about the diseases and they are trying to learn about the diseases so that they can avoid the situation. Diagnosis of disease: an important activity to save the poultry industry Disease creates problems in the good health of different parts of the body. Not only for human being, it is applicable for all the animals of the earth, which is very true about the

poultry chicken because they are very sensitive about any mismanagement. They need some extra care as they grow in a sensitive environment. They also may react in different weather and the diseases may attack climate and the chickens and hens if the environment is not controlled. That's why it very important to save them from any kind of diseases for marketing the poultry. Though generally farmers give vaccines to the poultry but it has been found that the poultry are becoming sick and epidemic. The reason behind is farmers do not check whether the vaccines are ineffective or not. Vaccines is use to protect the poultry from the diseases and microbes are entered through the vaccines and if microbes do not enter in sufficient amount and if the activity does not contain the security then the vaccination will be a lost project. As farmers have least idea about Ranikhet, Gamboro, Faul Pox, Infectitous Broncataties, Coccideosis, Infectus Coraiga, Aflatoxicosis, Eggdrop and there is a very high possibility to be infected by them, the farmers should have the clear concept about the diagnosis. If the farmers can detect the diseases beforehand then by taking preventive measures they can save some abnormal loss and that's why it is very important to know about the diagnosis of the diseases. As Bangladeshi farmers are weak in poultry management, in the same way they have lack of knowledge about the proper diagnosis of the poultry also. It is one of the major reasons that epidemic takes place. To save the poultry from all the diseases and infections the farmers should have a strict organic security and also they have to monitor whether the poultry conducting any unusual behavior or not. It's better to prevent them by taking the necessary action beforehand rather than taking the action to feed the medicines after the infection. This will give two advantage, one is it will save some unusual expenses and it will have less indirect effect on human body. So it will be a profitable thing if farmers take care about proper diagnosis of the poultry. That's why farmer should take necessary training on diagnosis and should maintain a regular communication with the diagnostic centers and if necessary there should special diagnostic zones adjacent to the big farms. The officials of different diagnostic centers can visit the farms often and through that the farmers can learn to diagnosis and to take the proper help form the concerned department. Government, Private sector and other big entrepreneurs can invest to establish diagnostic centers.

Foreign Investors can also be called for this. It is necessary to establish the latest and scientific diagnostic laboratory in Bangladesh. There are few diagnostic centers that are not sufficient enough to meet the demand of the poultry industry. It is agreed that to make the poultry industry profitable, it is necessary to give importance to the diagnosis sector and establish latest and scientific diagnostic centers. Animal health care products and ACI Pharmaceuticals In Bangladesh private sector investment in rural based agro-industries is significant enough. Established business houses are yet to divert their attention in such nontraditional propositions. However, towards end 80's a huge number of poultry farms have come up with keen interest in development of poultry sector and subsequently became active as multidimensional conglomerate. As a result it has been noticed that a strong demand has risen up for animal health care products among which different types of veterinary items are mostly noticeable. In Bangladesh per capita consumption of meat is below I kg. Assuming that, if we can increase this figure up to 1.5 kg then a dramatic change in our poultry sector can be observed. To fulfill this gap in between high demand and poor supply of animal health care products domestically ACI Pharmaceuticals has recently introduced a new product line that gives much emphasis on Vitamins (different kinds of vitamins which are required for the rapid growth of chicken) and Ox Tetracycline (a kind of medicine used for preserving poultry feed) required for poultry farming. This recent project follows up the company's new idea to establish a full-fledged animal health care division namely ACI health care division with its marketing infrastructure. The company has set up its target to gain 25% to 30% market share of the domestic market of animal health care products. Simultaneously, the project goal is to hold the position among the top five companies in the related field by the year 2005/2006. Within the next few months ACI Pharmaceutical is planning to launch their animal health based products in the market. As a result, in present days, they are passing through a situation, which need information to make decisions regarding the market of the products of animal heath care product line of the company. In this respect, the company is in a need to figure out the market potential for animal health based products.

As the prime products of this animal health care product line are Vitade (Vitamin 83Ad3E) and Oxin WS (Oxytetracycline Hydrochloride) the company is interested to consider these two products for measuring market potential. Here market potential has been defined as the current demand among the customers of our country for animal health care products of ACI Pharmaceuticals. Consumption of Animal Heath care products In this case ACI only concentrate to the information about the Animal health care products. Animal health care products increase in Consumption in many reasons: Festivals Like Eid Weather Fluctuation Seasonality Effect Temperature Fluctuation Others For these following-mentioned two generalized reasons the animal health care product will be getting popular day by day and that is why there is a market potentiality for this product. Increase in consumption for both the increases in demand during festivals, and fluctuation of weather. Increase in consumption during the pick season.